XML 97 R5.htm IDEA: XBRL DOCUMENT v3.24.4
Condensed Consolidated and Combined Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)
Common Stock
Class A
Common Stock
Class B
Common Stock
Previously Reported
Common Stock
Retroactive application of recapitalization
Common Stock
Adjusted
Common Stock
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Retroactive application of recapitalization
Additional Paid-in Capital
Adjusted
Additional Paid-in Capital
Accumulated Deficit
Previously Reported
Accumulated Deficit
Retroactive application of recapitalization
Accumulated Deficit
Adjusted
Accumulated Deficit
Stock Subscription Receivable
Previously Reported
Stock Subscription Receivable
Retroactive application of recapitalization
Stock Subscription Receivable
Adjusted
Stock Subscription Receivable
Previously Reported
Retroactive application of recapitalization
Adjusted
Total
Balance beginning at Dec. 31, 2021 $ 316               $ 24,684       $ (1,430)               $ 23,570
Balance beginning (in Shares) at Dec. 31, 2021 3,162,500                                        
Proceeds Allocated to Public Warrants               3,755,675                     3,755,675
Proceeds from Private Warrants               5,405,000                     5,405,000
Value of transaction costs allocated to the fair value of equity instruments               (234,654)                     (234,654)
Class A common stock issued to Representative $ 12               776,803                     776,815
Class A common stock issued to Representative (in Shares) 123,500                                          
Class A Common Stock Redeemable Remeasurement Adjustment at Initial Public Offering               (9,727,508)       (3,214,594)               (12,942,102)
Class A Common Stock Redeemable Remeasurement Adjustment                     (1,272,983)               (1,272,983)
Forfeiture of Class B Common Stock $ (8)                     8              
Forfeiture of Class B Common Stock (in Shares)   (75,000)                                        
Net income (loss)                     593,905               593,905
Balance ending at Dec. 31, 2022 $ 12 $ 308 $ 6,980 $ 6,980   $ 26,104,307 $ (6,980) $ 26,097,327 $ (20,120,881) $ (20,120,881) (3,895,094)         $ 5,983,426 $ 5,983,426 (3,894,774)
Balance ending (in Shares) at Dec. 31, 2022 123,500 3,087,500 69,800,000 69,800,000                                  
Contributions and net transfers with related parties               1,878,454                     1,878,454  
Net income (loss)                     (4,211,621)               (4,211,621)  
Balance ending at Sep. 30, 2023         $ 6,980 $ 6,980     27,975,781 27,975,781     (24,332,502) (24,332,502)             3,650,259 3,650,259
Balance ending (in Shares) at Sep. 30, 2023         69,800,000 69,800,000                                
Balance beginning at Dec. 31, 2022 $ 12 $ 308 $ 6,980 $ 6,980   26,104,307 (6,980) 26,097,327 (20,120,881) (20,120,881) (3,895,094)         5,983,426 5,983,426 (3,894,774)
Balance beginning (in Shares) at Dec. 31, 2022 123,500 3,087,500 69,800,000 69,800,000                                  
Class A Common Stock Redeemable Remeasurement Adjustment                     (3,972,489)               (3,972,489)
Excise tax on redemption of Class A Common Stock                     (890,385)               (890,385)
Net income (loss)                     (19,775,602)               (19,775,602)
Balance ending at Dec. 31, 2023 $ 12 $ 308 $ 6,980 $ 6,980   28,857,965 (6,980) 28,850,985 (25,445,506) (25,445,506) (28,533,570)   3,412,459 3,412,459 (28,533,250)
Balance ending (in Shares) at Dec. 31, 2023 123,500 3,087,500 69,800,000 69,800,000                                  
Balance beginning at Jun. 30, 2023           $ 6,980       26,732,540       (22,895,008)               3,837,532
Balance beginning (in Shares) at Jun. 30, 2023           69,800,000                                
Contributions and net transfers with related parties                 1,250,221                     1,250,221
Net income (loss)                       (1,437,494)               (1,437,494)
Balance ending at Sep. 30, 2023         $ 6,980 $ 6,980     27,975,781 27,975,781     (24,332,502) (24,332,502)             3,650,259 3,650,259
Balance ending (in Shares) at Sep. 30, 2023         69,800,000 69,800,000                                
Balance beginning at Dec. 31, 2023 $ 12 $ 308 $ 6,980 $ 6,980   $ 28,857,965 $ (6,980) 28,850,985 $ (25,445,506) (25,445,506) (28,533,570)   $ 3,412,459 3,412,459 (28,533,250)
Balance beginning (in Shares) at Dec. 31, 2023 123,500 3,087,500 69,800,000 69,800,000                                  
Capital contributions from related party               487,273                   487,273  
Issuance of common stock upon consummation of the Merger         $ 600       (27,888,519)                   (27,887,919)  
Issuance of common stock upon consummation of the Merger (in Shares)         6,004,741                                  
Conversion of convertible notes into common stock upon consummation of the Merger         $ 596       3,174,404                   3,175,000  
Conversion of convertible notes into common stock upon consummation of the Merger (in Shares)         5,962,325                                  
Stock subscription receivable                           (80,241)       (80,241)  
Earnout Arrangement               63,600,000       (63,600,000)              
Contingent consideration               906,000       (906,000)              
Shares issued from exercise of Series A Warrants         $ 47       162,007                   162,054  
Shares issued from exercise of Series A Warrants (in Shares)         466,000                                  
Shares issued from exercise of Series B Warrants         $ 536       1,384                   1,920  
Shares issued from exercise of Series B Warrants (in Shares)         5,364,046                                  
Issuance of common stock for Forward Purchase Agreement         $ 954       (954)                    
Issuance of common stock for Forward Purchase Agreement (in Shares)         9,543,002                                  
Issuance of common stock for Forward Purchase Agreement Compensation         $ 285       1,025,715                   1,026,000  
Issuance of common stock for Forward Purchase Agreement Compensation (in Shares)         2,850,000                                  
Private Placement         $ 1,735       12,930,262                   12,931,997  
Private Placement (in Shares)         17,350,800                                  
Stock-based compensation to consultant               700,000                   700,000  
Issuance costs in connection with the Private Placement               (419,499)                   (419,499)  
Stock-based compensation               2,088,838                   2,088,838  
Net income (loss)                     (14,384,526)             (14,384,526)  
Balance ending at Sep. 30, 2024         $ 11,733 $ 11,733     85,617,896 85,617,896     (104,336,032) (104,336,032)     (80,241) $ (80,241)     (18,786,644) (18,786,644)
Balance ending (in Shares) at Sep. 30, 2024         117,340,914 117,340,914                                
Balance beginning at Jun. 30, 2024           $ 8,709       79,610,239       (97,699,353)       (80,241)       (18,160,646)
Balance beginning (in Shares) at Jun. 30, 2024           87,100,341                                
Shares issued from exercise of Series A Warrants           $ 47       162,007                   162,054
Shares issued from exercise of Series A Warrants (in Shares)           466,000                                
Shares issued from exercise of Series B Warrants           $ 516       1,370                   1,886
Shares issued from exercise of Series B Warrants (in Shares)           5,164,103                                
Issuance of common stock for Forward Purchase Agreement           $ 954       (954)                  
Issuance of common stock for Forward Purchase Agreement (in Shares)           9,543,002                                
Issuance of common stock for Forward Purchase Agreement Compensation           $ 285       1,025,715                   1,026,000
Issuance of common stock for Forward Purchase Agreement Compensation (in Shares)           2,850,000                                
Private Placement           $ 1,222       3,998,778                   4,000,000
Private Placement (in Shares)           12,217,468                                
Stock-based compensation to consultant                 700,000                   700,000
Issuance costs in connection with the Private Placement                 (157,435)                   (157,435)
Stock-based compensation                 278,176                   278,176
Net income (loss)                       (6,636,679)             (6,636,679)
Balance ending at Sep. 30, 2024         $ 11,733 $ 11,733     $ 85,617,896 $ 85,617,896     $ (104,336,032) $ (104,336,032)     $ (80,241) $ (80,241)     $ (18,786,644) $ (18,786,644)
Balance ending (in Shares) at Sep. 30, 2024         117,340,914 117,340,914